| Purinergic Signalling | |
| Editor: | Charles Kennedy |
| Discipline: | Neuroscience |
| Abbreviation: | Purinergic Signal. |
| Publisher: | Springer Science+Business Media |
| Frequency: | Quarterly |
| History: | 2004-present |
| Impact: | 3.5 |
| Impact-Year: | 2022 |
| Website: | https://www.springer.com/biomed/journal/11302 |
| Link1-Name: | Online access |
| Link2: | https://link.springer.com/journal/volumesAndIssues/11302 |
| Link2-Name: | Online archive |
| Oclc: | 57767451 |
| Coden: | PSUIA9 |
| Issn: | 1573-9538 |
| Eissn: | 1573-9546 |
Purinergic Signalling is a quarterly peer-reviewed scientific journal covering research on purinergic signalling. It is published by Springer Science+Business Media and its editor-in-chief is Charles Kennedy. The founding editor was Geoffrey Burnstock.
The journal is abstracted and indexed in:According to the Journal Citation Reports, it had a 2012 impact factor of 2.635.[1]